Mass screening for neuroblastoma: quo vadis? A 9-year experience from the Pediatric Oncology Study Group of the Kyushu area in Japan.
Suita S, Zaizen Y, Sera Y, Takamatsu H, Mizote H, Ohgami H, Kurosaki N, Ueda K, Tasaka H, Miyazaki S, Sugimoto T, Kawakami K, Tsuneyoshi M, Yano H, Akiyama H, Ikeda K.
Suita S, et al. Among authors: ueda k.
J Pediatr Surg. 1996 Apr;31(4):555-8. doi: 10.1016/s0022-3468(96)90495-9.
J Pediatr Surg. 1996.
PMID: 8801312